- call +1-201-465-4211
- email sales@mrinsights.biz
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Scope of the Report:
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine industry is relatively fragmented, manufacturers are mostly in the North America, Europe and Asia, and China market production volume accounted for more than 25.43% of the total production volume of global Atropine in 2017. C²PHARMA is the world leading manufacturer in global Atropine market with the market share of 9.19%, in terms of revenue, followed by RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng Group and CR Double-Crane.
Compared to 2016, Atropine market decreased revenue by 5.69 percent to $549.60 million worldwide in 2017 from $582.76 million in 2016. As for the volume segment, global Atropine production decreased to 3862.8 Kg from 4247.4 Kg in 2013. Due to low prices, small profit margins and a relatively narrow market, many companies have abandoned production of atropine, and a shortage of atropine has appeared in the market. This is the result of long-term effects of market behavior.
The average price of Atropine will fall further. The product average price declined in the past few years due to its cheap drug properties, and the average price will keep this trend in the few future years due to market vicious circle.
The worldwide market for Atropine is expected to grow at a CAGR of roughly -1.6% over the next five years, will reach 500 million US$ in 2024, from 550 million US$ in 2019, according to a new study.
This report focuses on the Atropine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng Group
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Injection
Drop
Gel
Market Segment by Applications, can be divided into
Gastrointestinal
Ophthalmology
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Atropine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Atropine, with price, sales, revenue and global market share of Atropine in 2017 and 2018.
Chapter 3, the Atropine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Atropine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Atropine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Atropine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Atropine Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Drop
1.2.3 Gel
1.3 Market Analysis by Applications
1.3.1 Gastrointestinal
1.3.2 Ophthalmology
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 C²PHARMA
2.1.1 Business Overview
2.1.2 Atropine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 C²PHARMA Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 RESONANCE LABORATORIES
2.2.1 Business Overview
2.2.2 Atropine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 RESONANCE LABORATORIES Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 ROLABO OUTSOURCING
2.3.1 Business Overview
2.3.2 Atropine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ROLABO OUTSOURCING Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Minsheng Group
2.4.1 Business Overview
2.4.2 Atropine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Minsheng Group Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 CR Double-Crane
2.5.1 Business Overview
2.5.2 Atropine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CR Double-Crane Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 HENAN PURUI
2.6.1 Business Overview
2.6.2 Atropine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 HENAN PURUI Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Albany Molecular Research
2.7.1 Business Overview
2.7.2 Atropine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Albany Molecular Research Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Alchem International
2.8.1 Business Overview
2.8.2 Atropine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Alchem International Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 SAURAV CHEMICALS
2.9.1 Business Overview
2.9.2 Atropine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 SAURAV CHEMICALS Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Katsura Chemical
2.10.1 Business Overview
2.10.2 Atropine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Katsura Chemical Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hangzhou Vega
2.11.1 Business Overview
2.11.2 Atropine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hangzhou Vega Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Wuhan senwayer century
2.12.1 Business Overview
2.12.2 Atropine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Wuhan senwayer century Atropine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Atropine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Atropine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Atropine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Atropine Manufacturer Market Share in 2018
3.3.2 Top 6 Atropine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Atropine Market Analysis by Regions
4.1 Global Atropine Sales, Revenue and Market Share by Regions
4.1.1 Global Atropine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Atropine Revenue and Market Share by Regions (2014-2019)
4.2 North America Atropine Sales and Growth Rate (2014-2019)
4.3 Europe Atropine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Atropine Sales and Growth Rate (2014-2019)
4.5 South America Atropine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Atropine Sales and Growth Rate (2014-2019)
5 North America Atropine by Country
5.1 North America Atropine Sales, Revenue and Market Share by Country
5.1.1 North America Atropine Sales and Market Share by Country (2014-2019)
5.1.2 North America Atropine Revenue and Market Share by Country (2014-2019)
5.2 United States Atropine Sales and Growth Rate (2014-2019)
5.3 Canada Atropine Sales and Growth Rate (2014-2019)
5.4 Mexico Atropine Sales and Growth Rate (2014-2019)
6 Europe Atropine by Country
6.1 Europe Atropine Sales, Revenue and Market Share by Country
6.1.1 Europe Atropine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Atropine Revenue and Market Share by Country (2014-2019)
6.2 Germany Atropine Sales and Growth Rate (2014-2019)
6.3 UK Atropine Sales and Growth Rate (2014-2019)
6.4 France Atropine Sales and Growth Rate (2014-2019)
6.5 Russia Atropine Sales and Growth Rate (2014-2019)
6.6 Italy Atropine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Atropine by Country
7.1 Asia-Pacific Atropine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Atropine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Atropine Revenue and Market Share by Country (2014-2019)
7.2 China Atropine Sales and Growth Rate (2014-2019)
7.3 Japan Atropine Sales and Growth Rate (2014-2019)
7.4 Korea Atropine Sales and Growth Rate (2014-2019)
7.5 India Atropine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Atropine Sales and Growth Rate (2014-2019)
8 South America Atropine by Country
8.1 South America Atropine Sales, Revenue and Market Share by Country
8.1.1 South America Atropine Sales and Market Share by Country (2014-2019)
8.1.2 South America Atropine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Atropine Sales and Growth Rate (2014-2019)
8.3 Argentina Atropine Sales and Growth Rate (2014-2019)
8.4 Colombia Atropine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Atropine by Countries
9.1 Middle East and Africa Atropine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Atropine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Atropine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Atropine Sales and Growth Rate (2014-2019)
9.3 Turkey Atropine Sales and Growth Rate (2014-2019)
9.4 Egypt Atropine Sales and Growth Rate (2014-2019)
9.5 Nigeria Atropine Sales and Growth Rate (2014-2019)
9.6 South Africa Atropine Sales and Growth Rate (2014-2019)
10 Global Atropine Market Segment by Type
10.1 Global Atropine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Atropine Sales and Market Share by Type (2014-2019)
10.1.2 Global Atropine Revenue and Market Share by Type (2014-2019)
10.2 Injection Sales Growth and Price
10.2.1 Global Injection Sales Growth (2014-2019)
10.2.2 Global Injection Price (2014-2019)
10.3 Drop Sales Growth and Price
10.3.1 Global Drop Sales Growth (2014-2019)
10.3.2 Global Drop Price (2014-2019)
10.4 Gel Sales Growth and Price
10.4.1 Global Gel Sales Growth (2014-2019)
10.4.2 Global Gel Price (2014-2019)
11 Global Atropine Market Segment by Application
11.1 Global Atropine Sales Market Share by Application (2014-2019)
11.2 Gastrointestinal Sales Growth (2014-2019)
11.3 Ophthalmology Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Atropine Market Forecast (2019-2024)
12.1 Global Atropine Sales, Revenue and Growth Rate (2019-2024)
12.2 Atropine Market Forecast by Regions (2019-2024)
12.2.1 North America Atropine Market Forecast (2019-2024)
12.2.2 Europe Atropine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Atropine Market Forecast (2019-2024)
12.2.4 South America Atropine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Atropine Market Forecast (2019-2024)
12.3 Atropine Market Forecast by Type (2019-2024)
12.3.1 Global Atropine Sales Forecast by Type (2019-2024)
12.3.2 Global Atropine Market Share Forecast by Type (2019-2024)
12.4 Atropine Market Forecast by Application (2019-2024)
12.4.1 Global Atropine Sales Forecast by Application (2019-2024)
12.4.2 Global Atropine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Atropine Picture
Table Product Specifications of Atropine
Figure Global Sales Market Share of Atropine by Types in 2018
Table Atropine Types for Major M
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
